Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07018674 · ClinicalTrials.gov registry record · NA
Acute Cognitive Effects of Brain Edge
A NA study, sponsored by Nature's Sunshine Products.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07018674: Completed NA study, sponsored by Nature's Sunshine Products.
NCT07018674 is a NA study that has completed, run by Nature's Sunshine Products. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07018674, a NA study, has completed, sponsored by Nature's Sunshine Products.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
A double-blind placebo-controlled crossover study exploring the cognitive effects of Brain Edge; a supplement consisting of a blend of herbs and amino acids. 50 healthy adult subjects will be evaluated over 3 sessions. Evaluation of cognitive performance will be determined by computer-based software, surveys, and VR headset experiences.
Primary Outcome
Data collected at individual study visits will be used to assess participants for any adverse events associated with the study procedures or products. Subjects with ongoing adverse events will be followed until resolution at the discretion of the PI.
Interventions
- OTHER Placebo
- OTHER Water
- DIETARY_SUPPLEMENT Experimental
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-08-20 |
| Est. Completion | 2025-11-20 |
| Phase | NA |
What the finished NCT07018674 record still lists
NCT07018674 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07018674 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07018674 about?
NCT07018674 is a clinical study titled "Acute Cognitive Effects of Brain Edge". A double-blind placebo-controlled crossover study exploring the cognitive effects of Brain Edge; a supplement consisting of a blend of herbs and amino acids. 50 healthy adult subjects will be evaluated over 3 sessions. Evaluation of cognitive performance will be determined by computer-based software...
What is the current status of trial NCT07018674?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2025-08-20. Estimated completion is 2025-11-20.
What interventions are being tested in trial NCT07018674?
The interventions under investigation include: Placebo (OTHER), Water (OTHER), Experimental (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07018674?
This trial is sponsored by Nature's Sunshine Products, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07018674's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI